QSAM BIOSCIENCES
QSAM Biosciences is a developer of nuclear medicines for the treatment of cancer and related diseases and conditions. Its initial technology is Samarium-153 DOTMP, aka CycloSam, a clinical-stage bone targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, leaders in the nuclear medicine space who also developed FDA-approved and commercially available Quadramet® (Samarium-153 EDTMP), indicated for pain palliation. CycloSam was assigned to IsoTherapeutics Group’s subsidiary, IGL Pharma, Inc.
QSAM BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2004-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.qsambio.com
Total Employee:
1+
Status:
Active
Total Funding:
200 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Promethean Life Sciences
Promethean Life Sciences develops allograft skin products for the treatment of chronic and traumatic wounds, and reconstructive surgery.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Viatris
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Official Site Inspections
http://www.qsambio.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K
- Host name: 104.21.24.27
- IP address: 104.21.24.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "QSAM Biosciences"
QSAM Biosciences - Crunchbase Company Profile & Funding
QSAM Biosciences is a developer of nuclear medicines for the treatment of cancer and related diseases and conditions. Its initial technology is Samarium-153 DOTMP, aka CycloSam, a …See details»
QSAM Biosciences Company Profile 2024: Valuation, …
QSAM Biosciences General Information Description. Telix QSAM Inc formerly QSAM Biosciences Inc is a clinical-stage novel radiopharmaceutical company. …See details»
QSAM Biosciences, Inc. | LinkedIn
QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP …See details»
QSAM Biosciences - Overview, News & Similar companies
Apr 16, 2024 QSAM ANNOUNCES REVERSE STOCK SPLIT RATIO AHEAD OF MERGER Austin, TX, April 16, 2024 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM) …See details»
QSAM Biosciences - Company Profile - Tracxn
Dec 5, 2024 QSAM Biosciences - Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation. Public Company. Raised funding over 2 rounds …See details»
QSAM Biosciences, Inc. Overview | SignalHire Company Profile
Organization Website: qsambio.com : Phone Number: 5123434558: QSAM Biosciences, Inc. industries Biotech: Headquarters Location: 9442 N Capital of Texas Hwy, Austin, Texas, …See details»
QSAM Biosciences | Treatment of Bone Cancer
We would like to show you a description here but the site won’t allow us.See details»
QSAM Biosciences | VentureRadar
Website: https://qsambio.com/ QSAM Biosciences is committed to advancing the fight against cancer through discovery, development and delivery of effective treatment ...See details»
QSAM Biosciences Company Profile: Overview and Full News …
Qsambio.com. Biometrics Pharmaceuticals Healthcare IT Life Sciences Medical Technology. Overview: QSAM Biosciences. QSAM Biosciences is a Texas-based company that operates in …See details»
Organization: QSAM Biosciences - Cbonds.com
QSAM Biosciences. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Qsam Biosciences Inc (QSAM) $8.30 (NASDAQ) Share Price Today
May 2, 2024 Website https://qsambio.com; Business. QSAM Biosciences, Inc. engages in developing various nuclear medicines for the... treatment of cancer. The company is involved …See details»
QSAM Biosciences-QSAM Biosciences, Inc.-企业详情-InvestGO数 …
Dec 31, 2003 查看医药魔方InvestGO®数据库QSAM Biosciences的公司信息。QSAM Biosciences（QSAM Biosciences, Inc.），公司简介：We are developing next-generation …See details»
QSAM Biosciences, Inc. - discovery.patsnap.com
Discovery Company profile page for QSAM Biosciences, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
QSAM Biosciences Issues Letter from New CEO; Presents …
Nov 24, 2020 QSAM Biosciences is a clinical stage company developing effective therapeutic radiopharmaceuticals for bone cancer & bone marrow ablationSee details»
QSAM Biosciences | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
QSAM Biosciences Seeks to Expand Radiochemical Assets; Signs …
Mar 17, 2021 QSAM Biosciences, Inc. (OTCQB: QSAM) announced today that it has signed an Exclusive Option Agreement with IsoTherapeutics Group, LLC to allow the Company a 120 …See details»
QSAM Biosciences Activates Clinical Sites and Opens
Dec 1, 2021 [email protected]. Media: Jules Abraham CORE IR 917-885-7378 [email protected]. Clinical Trial: Laura T. Guerra, RN, CCRC Oncology Consultants 713-600 …See details»
Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs …
Apr 28, 2020 QSAM Biosciences is a clinical stage company developing effective therapeutic radiopharmaceuticals for bone cancer & bone marrow ablationSee details»
QSAM Biosciences, Inc. (QSAM Biosciences, Inc.) - 药物管线_专利_ …
了解QSAM Biosciences, Inc. (QSAM Biosciences, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 20篇新闻，疾病领域:肿瘤，内分泌与代谢疾病，技术平台:治疗用放射药 …See details»
Qsam Biosciences - Facebook
Qsam Biosciences is on Facebook. Join Facebook to connect with Qsam Biosciences and others you may know. Facebook gives people the power to share and...See details»